5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.16▼ | 3.21▼ | 3.22▼ | 3.42▼ | 3.10▲ |
MA10 | 3.17▼ | 3.23▼ | 3.33▼ | 3.37▼ | 2.89▲ |
MA20 | 3.20▼ | 3.36▼ | 3.43▼ | 3.17▼ | 3.00▲ |
MA50 | 3.30▼ | 3.48▼ | 3.41▼ | 2.86▲ | 2.54▲ |
MA100 | 3.41▼ | 3.39▼ | 3.23▼ | 2.97▲ | 2.87▲ |
MA200 | 3.46▼ | 3.20▼ | 3.04▲ | 2.73▲ | 7.23▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.018▼ | -0.045▼ | -0.009▼ | 0.019▲ |
RSI | 29.480▼ | 26.625▼ | 32.083▼ | 49.636▼ | 55.803▲ |
STOCH | 8.063▼ | 12.343▼ | 7.923▼ | 51.845 | 66.398 |
WILL %R | -88.235▼ | -97.959▼ | -98.000▼ | -71.287 | -45.570 |
CCI | -69.099 | -105.706▼ | -111.880▼ | -51.114 | 77.782 |
Thursday, October 09, 2025 09:00 AM
Austin, Texas, United States, October 9th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has ...
|
Monday, October 06, 2025 09:30 AM
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly owned subsidiary HOPE Therapeutics Inc., announced that Founder, Chairman, and CEO Dr. Jonathan Javitt ...
|
Monday, October 06, 2025 05:17 AM
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/10/25 | 3.24 | 3.24 | 3.10 | 3.12 | 315,011 |
10/10/25 | 3.59 | 3.59 | 3.14 | 3.17 | 667,105 |
09/10/25 | 3.60 | 3.6763 | 3.42 | 3.56 | 445,536 |
08/10/25 | 3.66 | 3.7499 | 3.46 | 3.58 | 371,464 |
07/10/25 | 3.35 | 3.84 | 3.32 | 3.67 | 651,013 |
06/10/25 | 3.29 | 3.44 | 3.27 | 3.35 | 550,088 |
03/10/25 | 3.33 | 3.3893 | 3.23 | 3.27 | 297,877 |
02/10/25 | 3.38 | 3.40 | 3.20 | 3.33 | 260,175 |
01/10/25 | 3.31 | 3.40 | 3.19 | 3.34 | 323,994 |
30/09/25 | 3.27 | 3.48 | 3.20 | 3.30 | 438,852 |
|
|
||||
|
|
||||
|
|